Journal of pharmaceutical sciences · 2025
pH-Responsive carbon dot-metal organic gel nanocarrier for visible light-triggered chemo-photodynamic cancer therapy and targeted drug delivery.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Maiti Sayani, Maity Debjit, Roy Baidyanath, Pal Aparajita, Ghosh Priya, Nandan Supratik, Mandal Mahitosh, Goswami Ritobrata, Das Narayan Chandra, Banerjee Susanta
Аннотация
This abstract describes a novel, stimulus-responsive drug delivery system for cancer therapy, emphasizing a biodegradable, targeted approach to minimize side effects. The system utilizes a Fe-based metal organic coordination gel (MOG) with a porous structure, designed for high-capacity drug loading and Fenton reaction facilitation to destroy cancer cells. The MOG, synthesized via a simple, eco-friendly method, demonstrates peroxidase-like behavior under visible light, enhancing Fenton-type reactions. Carbon dots (CDs), produced through a hydrothermal process, are incorporated for bio-imaging and tracking, while the anti-cancer drug 5 Fluorouracil (5 FU) is loaded with a high capacity of 72.9 %. This system ensures controlled drug release in acidic environments, reducing premature leakage and side effects on healthy cells. A 450 nm light source enhances Fe²⁺ stability, where Fe³⁺ released in acidic cancerous environments converts to Fe²⁺ by photo reduction process and reacts with cellular H₂O₂, producing hydroxyl radicals (HO•) that oxidize critical cellular components, inhibiting cancer growth. Cellular uptake and cytotoxicity were evaluated in various cell lines, with MTT assays revealing selective toxicity to folate-positive HeLa cancer cells, showing reduced effects on comparatively less folate-positive MDA-MB-231 cells and non-cancerous L929 cells. This innovative approach combines pH-responsive chemo-photodynamic therapy with bio-sensing and imaging in one platform, demonstrating significant promise in advanced cancer treatment applications.